Kidney transplantation in catastrophic antiphospholipid syndrome survivors: Results from a nationwide series of 12 cases

This publication has 20 references indexed in Scilit:

• Complement in antiphospholipid syndrome, time to target?
  Current Opinion in Immunology, 2025
• De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury
  American Journal of Transplantation, 2024
• CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT
  Retina, 2021
• KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
  Transplantation, 2020
• An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome
  American Journal of Kidney Diseases, 2019
• The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients
  Rheumatology, 2018
• Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
  New England Journal of Medicine, 2014
• Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the “CAPS Registry”
  Journal of Autoimmunity, 2009
• FREQUENCY, POTENTIAL RISK AND THERAPEUTIC INTERVENTION IN END-STAGE RENAL DISEASE PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME
  Transplantation, 2000
• Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant
  New England Journal of Medicine, 1999